758 件 ・ 関連度順
概要と使いどころ
Structured multi-criteria decision analysis for ranking options with weights, constraints, confidence, tradeoff reasoning, sensitivity analysis, and explainable recommendations. Use when the user asks for decision support, MCDA, weighted scoring, prioritization, vendor selection, route planning, hiring shortlist ranking, tool comparison, procurement decisions, or auditable agent decision logic.
日本語の概要は準備中です。原文の説明を表示しています。
Select, write, or review proportionate tests and verification for dygo Go packages, PostgreSQL behavior, metadata, CLI contracts, Studio, integrations, and releases. Use when test scope or confidence strategy is the main decision.
日本語の概要は準備中です。原文の説明を表示しています。
Drafts U.S. bulk sales compliance packages for asset purchase transactions outside the ordinary course, including UCC Article 6 jurisdictional analysis, creditor schedules, notice of intended bulk sale, seller affidavit, escrow framework, and closing checklist. Use when handling bulk sale, bulk transfer, inventory sale, asset purchase compliance, creditor notice, or successor liability avoidance.
日本語の概要は準備中です。原文の説明を表示しています。
对网站进行全面 GDPR 合规审计。按照 10 个部分的检查清单（法律声明、 托管服务商、表单、新闻通讯、隐私政策、cookies 及横幅、 密码、跟踪器和受众测量、次级处理方及欧盟境外转移、权利收集的可及性） 对网站进行系统性观察，另附一项 22 项附录，再现 GDPR 第 13 条和第 14 条的要求。产出 结构化报告，包含整体合规水平、阻塞点 （风险 3）、需警惕点（风险 2）、优先建议 和技术说明。 该 skill 是工具无关的：它可通过自动导航 工具（Claude in Chrome、Cowork 或同类工具）运行，也可采用降级 复制粘贴模式。 触发词："audit RGPD site"、"audit site internet"、"vérifie ce site"、 "scanne ce site"、"audit conformité site"、"audite la conformité de [URL]"、 "audit cookies site"、"audit politique de confidentialité site"。
日本語の概要は準備中です。原文の説明を表示しています。
Drafts U.S. litigation attorney representation agreements for client onboarding, covering scope, fees, retainers, confidentiality, conflicts, duties, withdrawal, and dispute resolution. Use when converting consultations into enforceable engagement terms for civil litigation matters including personal injury. Trigger: engagement letter, litigation retainer, representation agreement, fee contract, conflict disclosure, attorney withdrawal, client acknowledgment.
日本語の概要は準備中です。原文の説明を表示しています。
Drafts U.S. commercial real estate access and indemnity (right-of-entry) agreements for pre-closing due diligence. Covers license grants, non-invasive vs invasive testing gates, insurance/endorsement requirements, indemnity with discovery carve-outs, restoration and lien remedies, confidentiality, and anti-indemnity guardrails. Trigger: access agreement, right of entry, due diligence access, Phase I/II, invasive testing, pre-PSA site inspection.
日本語の概要は準備中です。原文の説明を表示しています。
AI compliance analysis for EU AI Act, ISO 42001, NIST AI RMF, GDPR, OECD, financial services regulations (SEC, FCA, FINRA, DORA, MiFID II), and other frameworks. Use when asked to generate a compliance checklist for an AI tool or use case, determine if a risk assessment is required, score an AI tool's risk level, identify where an AI tool or use case could run afoul of regulatory requirements, perform a gap analysis, recommend remediation steps, assess a vendor, draft an acceptable use policy, map training requirements, or review jurisdiction-specific AI rules. Triggers on phrases like "compliance checklist", "risk assessment", "risk score", "does this comply", "EU AI Act", "ISO 42001", "NIST AI RMF", "AI governance", "gap analysis", "vendor assessment", "acceptable use policy", "MNPI", "AI training requirements", or any request to evaluate an AI tool or use case for regulatory compliance or risk.
日本語の概要は準備中です。原文の説明を表示しています。
Chief Security Officer mode. Infrastructure-first security audit: secrets archaeology, dependency supply chain, CI/CD pipeline security, LLM/AI security, skill supply chain scanning, plus OWASP Top 10, STRIDE threat modeling, and active verification. Two modes: daily (zero-noise, 8/10 confidence gate) and comprehensive (monthly deep scan, 2/10 bar). Trend tracking across audit runs. Use when: "security audit", "threat model", "pentest review", "OWASP", "CSO review".
日本語の概要は準備中です。原文の説明を表示しています。
Research-validated planning — research → plan → verify cycle for high-confidence implementation plans
日本語の概要は準備中です。原文の説明を表示しています。
Pragmatic testing guidance focused on confidence, behavior over implementation details, and integration-first coverage. Use when designing a test strategy, writing or reviewing tests, reducing brittle mocks, or deciding what is worth testing in an application or library.
日本語の概要は準備中です。原文の説明を表示しています。
Synthesizes actionable feedback from validation results, confidence scores, and iteration triggers. Creates structured improvement guidance for re-execution. Activate on 'synthesize feedback', 'improvement suggestions', 'actionable feedback', 'iteration guidance', 'feedback generation'. NOT for iteration detection (use dag-iteration-detector) or convergence tracking (use dag-convergence-monitor).
日本語の概要は準備中です。原文の説明を表示しています。
Call germline SNPs and indels with GATK HaplotypeCaller and the GVCF joint-genotyping workflow. Covers the local-reassembly + PairHMM mechanism (why HC beats pileup callers on indels), the -ERC GVCF reference-confidence model and <NON_REF> allele, BQSR-vs-DRAGSTR and --dragen-mode error modeling, allele-specific (AS_) annotations, and edge cases (ploidy, Mutect2 mitochondria mode, sex chromosomes/PAR, contamination gating). Use when deciding whether to use HaplotypeCaller vs a pileup or DRAGEN caller, whether BQSR still earns its place, whether to call per-sample GVCFs for a cohort, or how to handle non-diploid, mitochondrial, sex-chromosome, or contaminated samples. Not for post-calling filtering depth (see variant-calling/filtering-best-practices) or cohort joint-genotyping scaling (see variant-calling/joint-calling).
日本語の概要は準備中です。原文の説明を表示しています。
Quality control for pooled CRISPR screens covering library representation, Gini index, log-skew, replicate Pearson and Spearman concordance, essentialome precision-recall AUC against CEGv2 (Hart 2017), Cas9 cut-toxicity diagnostics, copy-number amplicon detection (Aguirre 2016 / Munoz 2016), bottleneck propagation through plasmid pool, infection, selection, and endpoint stages, MOI verification, and DepMap-style screen-quality scoring. Use when assessing screen quality before hit calling, deciding whether to repeat or rescue a screen, diagnosing low-confidence hits, choosing between MAGeCK / BAGEL2 / Chronos based on quality grade, picking a normalization strategy from QC signatures, or evaluating whether an in-vivo screen retained adequate library complexity.
日本語の概要は準備中です。原文の説明を表示しています。
Cross-method decision tree for calling hits in pooled CRISPR screens. Catalogs statistical models (MAGeCK RRA, MAGeCK MLE, BAGEL2, drugZ, JACKS, Chronos, CERES), experimental designs each is built for, failure modes outside design domain, reconciliation when methods disagree, multiple-testing and effect-size thresholds, the order of operations (count -> QC -> CN-correct -> hit-call -> validate), the second-best-sgRNA conservative rule, and consensus-hit strategy. Use when choosing among MAGeCK / BAGEL2 / drugZ / JACKS / Chronos for a given design, reconciling disagreement across two or three methods on the same screen, deciding whether to require consensus, gating downstream validation by hit-confidence tier, or interpreting unstable hit lists across reruns.
日本語の概要は準備中です。原文の説明を表示しています。
Computes and interprets treatment effect measures (OR, RR, RD, HR, NNT) with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen, MOVER, profile likelihood, Bender NNT) and reports marginal vs conditional estimands per FDA 2023 covariate adjustment guidance. Use when reporting treatment effects in confirmatory trials, comparing effect sizes across studies, or constructing forest plots.
日本語の概要は準備中です。原文の説明を表示しています。
Tests associations between categorical variables in clinical data using chi-square, Fisher's exact, Boschloo, Cochran-Mantel-Haenszel, and modern McNemar variants with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen). Use when analyzing categorical outcomes, paired binary endpoints, or testing treatment-outcome independence in confirmatory or exploratory clinical trials.
日本語の概要は準備中です。原文の説明を表示しています。
Validate protein designs using AlphaFold2 structure prediction. Use this skill when: (1) Validating designed sequences fold correctly, (2) Predicting binder-target complex structures, (3) Calculating confidence metrics (pLDDT, pTM, ipTM), (4) Self-consistency validation of designs, (5) Multi-chain complex prediction with AlphaFold-Multimer. For faster single-chain prediction, use esm. For QC thresholds, use protein-qc.
日本語の概要は準備中です。原文の説明を表示しています。
Access AlphaFold's 200M+ AI-predicted protein structures. Retrieve structures by UniProt ID, download PDB/mmCIF files, analyze confidence metrics (pLDDT, PAE), for drug discovery and structural biology.
日本語の概要は準備中です。原文の説明を表示しています。
Clone or recreate a live website URL, page, or section as React + Tailwind with extracted DOM, CSS, assets, responsive layout, motion, and interactions. Use for live-URL implementation or fidelity repair; not capture-only or diff-only requests.
日本語の概要は準備中です。原文の説明を表示しています。
Verify every claim from multiple independent angles -- code, docs, tests, git history. Use when you need high confidence that something is correct before acting on it.
日本語の概要は準備中です。原文の説明を表示しています。
Subjects every non-trivial decision to a fresh-context adversarial review before it stands. Use when correctness matters more than speed, when working in unfamiliar code, when stakes are high (production, security-sensitive logic, irreversible operations), or any time a confident output would be cheaper to verify now than to debug later.
日本語の概要は準備中です。原文の説明を表示しています。
Pressure-test an existing plan or design artifact until it is coherent enough for the next workflow step or plainly blocked. Use when the user wants to be grilled on a plan, design doc, PRD, ADR, rollout plan, migration runbook, rolling-wave project shape, or slice contract; when they say "grill me"; or when Codex should interrogate a source-of-truth artifact, inspect code and adjacent docs before asking, auto-answer evidence-backed questions, ask only about conflicts or low-confidence recommendations, edit the original file in place, preserve the artifact's existing format, and keep conclusions, blockers, readiness, and deferred work synchronized in the document.
日本語の概要は準備中です。原文の説明を表示しています。
Review local git changes before opening a PR or merging. First review all local tracked and untracked files; if none exist, review the current branch against a requested base branch or the Git Town parent branch. Use zero to three review subagents only when risk, diff size, language specificity, or uncertainty justifies the token cost, then report high-confidence bugs, regressions, risky assumptions, and missing tests. Use when the user asks for code review, local review, branch sanity check, pre-PR review, or review of work-in-progress changes.
日本語の概要は準備中です。原文の説明を表示しています。
How to test the peoplereadme CLI end-to-end, including the fidelity harness (eval/calibrate) with a synthetic persona fixture and live LLM calls.
日本語の概要は準備中です。原文の説明を表示しています。